Clinical Trial

3D Evaluation of Maxillary Expansion Methods

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
This controlled prospective clinical trial aims to evaluate the effectiveness of different maxillary expansion methods in children with maxillary transverse deficiency. A total of 60 participants will be included: 20 patients will receive Invisalign Palatal Expander (IPE), 20 will receive acrylic cap splint Rapid Maxillary Expansion (RME), and 20 will serve as an untreated control group. Three-dimensional (3D) intraoral and extraoral scans will be taken at the end of expansion, at 3 months, and at 6 months. Primary outcomes include maxillary arch width, first molar angulation, palatal surface area, and palatal volume. Secondary outcomes include soft tissue changes in the facial region. This study provides a direct comparison between a traditional and a modern digital expansion method, generating evidence for clinical decision-making in pediatric orthodontics.
Trial Details
NCT Number NCT07262892
Lead Sponsor Büşra Zeynep Yörük
Collaborators: Centerdent Orthodontics & Aesthetic Dentistry Clinic
Conditions Maxillary Transverse Deficiency
Enrollment 60 participants
Start Date 2025-11-20
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2025-12-04